Men's Health
MEN'S SEXUAL HEALTH
Programa Bate Papo na Saúde, Canal Saúde – Fiocruz
Aired on 30/03/2015
Programa Bate Papo na Saúde, Canal Saúde – Fiocruz
Aired on 30/03/2015
Os Homens vivem 7,59 anos menos que as mulheres. Dados do Instituto Brasileiro de Geografia e Estatística (IBGE) revelam que, embora a expectativa de vida dos homens tenha aumentado de 63,15 para 69,42 anos de 1991 para 2009, ela ainda se mantém muito abaixo da média das mulheres.
The main cause of death in men was ischemic heart disease, including acute myocardial infarction. In all, 49,128 men died from this cause. Cerebrovascular diseases were the second leading cause of death for men, with 45,180 deaths. The two causes can be grouped together as cardiovascular diseases, totaling 94,308 deaths in men. These diseases are mainly caused by endothelial lesions (blood vessels).
These lesions are first visible in the smaller vessels, such as the penile artery (1-2 mm). Occlusion of these vessels causes erectile sexual dysfunction (ESD) or lack of erection.
Ponholzer et al demosntraram que a doença arterial coronariana é 65% maior em homens com DSE moderada à grave do que em homens normais.
Inman et al observaram que pacientes com DSE tem um risco 80% maior para o infarto agudo do miocárdio, quando comparados a outros indivíduos normais. Homens entre 40 e 49 anos de idade que apresentem DSE moderada à grave possuem um risco 50 vezes maior de desenvolverem doenças cardiovasculares.
In addition to ESRD, we have another important factor for cardiovascular disease in men: the reduction in testosterone with age, known as Late Onset Hypogonadism (LOH), which affects 6% of the male population at the age of 40 and 12.3% at the age of 69.
Recent data in the literature shows that the age-related increase in the risk of coronary heart disease appears in conjunction with a reduction in testosterone.
Patients undergoing hormone blockade, i.e. removal of testosterone from circulation (castration) due to prostate cancer, are at high risk of coronary heart disease due to the marked reduction in serum testosterone. Male hormone replacement is an important factor in the quest to reduce the incidence of cardiovascular disease. It leads to a reduction in cholesterol, greater exercise tolerance, greater sensitivity to insulin action (helping to control diabetes), a reduction in the thickness of the artery wall and a reduction in inflammatory factors in the endothelium (vessel).
Considerando o exposto, cada homem deve reconhecer que não é imortal nem imune à doenças. Reconhecer suas limitações e procurar um atendimento médico adequado é essencial para se viver com saúde.
The main cause of death in men was ischemic heart disease, including acute myocardial infarction. In all, 49,128 men died from this cause. Cerebrovascular diseases were the second leading cause of death for men, with 45,180 deaths. The two causes can be grouped together as cardiovascular diseases, totaling 94,308 deaths in men. These diseases are mainly caused by endothelial lesions (blood vessels).
These lesions are first visible in the smaller vessels, such as the penile artery (1-2 mm). Occlusion of these vessels causes erectile sexual dysfunction (ESD) or lack of erection.
Ponholzer et al demosntraram que a doença arterial coronariana é 65% maior em homens com DSE moderada à grave do que em homens normais.
Inman et al observaram que pacientes com DSE tem um risco 80% maior para o infarto agudo do miocárdio, quando comparados a outros indivíduos normais. Homens entre 40 e 49 anos de idade que apresentem DSE moderada à grave possuem um risco 50 vezes maior de desenvolverem doenças cardiovasculares.
In addition to ESRD, we have another important factor for cardiovascular disease in men: the reduction in testosterone with age, known as Late Onset Hypogonadism (LOH), which affects 6% of the male population at the age of 40 and 12.3% at the age of 69.
Recent data in the literature shows that the age-related increase in the risk of coronary heart disease appears in conjunction with a reduction in testosterone.
Patients undergoing hormone blockade, i.e. removal of testosterone from circulation (castration) due to prostate cancer, are at high risk of coronary heart disease due to the marked reduction in serum testosterone. Male hormone replacement is an important factor in the quest to reduce the incidence of cardiovascular disease. It leads to a reduction in cholesterol, greater exercise tolerance, greater sensitivity to insulin action (helping to control diabetes), a reduction in the thickness of the artery wall and a reduction in inflammatory factors in the endothelium (vessel).
Considerando o exposto, cada homem deve reconhecer que não é imortal nem imune à doenças. Reconhecer suas limitações e procurar um atendimento médico adequado é essencial para se viver com saúde.
